Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000017

Chief Operating Officer acquired 32,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sandler Laura Lee · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-23 Grant or award : show line 1 in the form +32,500 237,584 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-23 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +130,000 130,000 D
Loading xslF345X05/form4.xml…